Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

A. Gronchi, S. Ferrari, V. Quagliuolo, J.M. Broto, A.L. Pousa, G. Grignani, U. Basso, J.-Y. Blay, O. Tendero, R.D. Beveridge, V. Ferraresi, I. Lugowska, D.F. Merlo, V. Fontana, E. Marchesi, D.M. Donati, E. Palassini, E. Palmerini, R. De Sanctis, C. MorosiS. Stacchiotti, S. Bagué, J.M. Coindre, A.P. Dei Tos, P. Picci, P. Bruzzi, P.G. Casali, Manuela Monti

Research output: Contribution to journalArticle

Cite this